tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics (DE:9IB)
:9IB
Germany Market
Advertisement

Infant Bacterial Therapeutics AB (9IB) Cash flow

Compare
4 Followers

Infant Bacterial Therapeutics AB Cash Flow

DE:9IB's free cash flow for Q1 2025 was kr-27.98M. For the 2025 fiscal year, DE:9IB's free cash flow was decreased by kr-11.91M and operating cash flow was kr-27.98M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -113.13Mkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39M
Investing Cash Flow
kr 0.00kr -4.15Mkr -1.00Kkr 0.00kr 0.00
Financing Cash Flow
kr 2.01Mkr 96.52Mkr 1.88Mkr 91.00Kkr 1.76M
End Cash Position
kr 223.39Mkr 329.06Mkr 335.84Mkr 386.75Mkr 423.44M
Free Cash Flow
kr -113.13Mkr -101.22Mkr -85.80Mkr -55.62Mkr -58.39M
Currency in SEK

Infant Bacterial Therapeutics AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis